We provide contract analysis services utilizing mass spectrometry imaging. This technology enables visualization of “where, what components, and how much.” It is applicable to pharmacokinetic studies, cosmetic development, and various other fields.
Development and sales of solutions for preventing the worsening of diabetes complications.
A startup developing a tooth regeneration drug that enables the regeneration of missing teeth in congenital anodontia by utilizing neutralizing antibodies that suppress molecules inhibiting tooth germ growth.
Some children suffer from learning disabilities and experience difficulties in daily life due to poor eye movement, which makes it difficult to read and to play sports. We are developing an evidence-based system that uses eye tracking and eye movement indexing technologies to assess eye movements and provide training for children who are encountering these eyesight challenges. We are currently deploying this system in municipal consultation centers, elementary schools, and after-school day care centers.
Optogenetics is an innovative neural photostimulation technology, with significant contributions from Japanese researchers whose expertise is highly regarded worldwide. Close collaboration with Nagoya Institute of Technology and Kyoto University is advancing the development of high-sensitivity rhodopsins specialized for vision restoration. This technology overcomes the longstanding issue of insufficient light sensitivity in the field of vision restoration. Furthermore, through joint research with Keio University School of Medicine, applied research on the foundational technology is progressing toward the practical realization of the world’s first gene therapy for vision restoration. The goal is to offer new treatment options for patients suffering from blindness or severe visual impairments.